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The alpha actinin (ACTN) family proteins are actin-bun-
dling proteins that are evolutionarily conserved and pos-
sess several functional domains. Vertebrates including 
humans express four unique actinin genes that display 
distinct expression patterns and biochemical properties. 
Mutations in each of these actinins are associated with 
tissues-specific abnormalities. ACTN1 and ACTN4 are 
ubiquitously expressed and their major spliced isoforms 
harbor calcium-sensitive EF hands, while the expression 
of ACTN2 and ACTN3 are primarily restricted to muscle 
and are calcium-insensitive.
Due to their ability to bind filamentous actin, ACTNs 
have been shown to regulate cytokinesis, cell adhe-
sion, spreading, migration and signaling. In addition, a 
fraction of ACTN4 is localized in the nucleus where it 
interacts with transcription factors, histone modifying 
enzymes and chromatin remodeling proteins in order to 
stimulate transcription [1–3]. Notably, all ACTNs harbor 
an evolutionarily conserved motif,—LXXLL—(L, leucine, 
X, any amino acids), which is required for interaction 
with the nuclear receptor family of transcription factors 
[3]. Indeed, ACTN1 and ACTN2 have been shown to 
enhance nuclear receptor-mediated transcription [1, 4]. 
Thus, ACTNs join the list of several other cytoskeletal 
proteins that are capable of shuttling between the cyto-
plasm and the nucleus to control cell function [5].
In this thematic review series, we feature recent pro-
gress in our understanding of the biological and the path-
ological roles of the ACTNs and genetic lesions in this 
protein family that are associated with human diseases.
Murphy and Young [6] first summarize genetic stud-
ies of actinin in invertebrates and cast an evolutionary 
perspective of this unique actin-binding protein family. 
They detail the similarities and differences among the 4 
vertebrate ACTNs and provide an insightful discussion of 
actinin-related genetic disorders with primary focus on 
ACTN1, 2 and 3. For example, mutations in ACTN1 are 
associated with dominantly-inherited congenital macro-
thrombocytopenia (CMPT), a rare blood disorder, while 
mutations in ACTN2 are linked to hypertrophic car-
diomyopathy (HCM). Interestingly, disease-associated 
ACTN1 and ACTN2 mutations are only found in the 
actin-binding domain, emphasizing the physiological sig-
nificance of this functional domain. Surprisingly, ACTN3 
is not essential and individuals with ACTN3 null alleles, 
due to a homozygous premature stop codon, are found in 
16 % of world population. Interestingly, wild-type allele is 
found to be associated with better sprint and power per-
formance in Caucasians.
ACTN4 was initially identified in a screen for antigens 
to which antibodies strongly reacted in highly invasive 
breast cancer [7]. Honda reviews recent literature on 
the link between ACTN4 amplification, overexpression 
and spliced variants that predict metastatic potency in 
several types of tumors including breast, prostate, colon 
and lung [8]. He also summarizes evidence supporting a 
role of ACTN4 in transcriptional regulation by nuclear 
receptors and NF-κB and its link to tumorigenesis. Lastly, 
Honda suggests that ACTN4 may be a useful biomarker 
for evaluating treatment option in metastatic breast 
cancer.
An elegant human genetics study has linked ACTN4 
mutations to the kidney disorder focal segmental glomer-
ular sclerosis (FSGS) [9]. This finding pioneered a novel 
concept that mutations in genes encoding cytoskeletal 
proteins in podocytes may be linked to glomerulopathy. 
Indeed, mutations of several cytoskeletal proteins have 
been subsequently found in patients with familial FSGS 
[10]. Interestingly, reduced expression of ACTN4 pro-
tein in kidney was also found in sporadic FSGS, mini-
mal change disease and IgA nephropathy. Feng et  al., 
thoroughly discusses the clinical presentation and bio-
chemical and biophysical properties of disease causing 
ACTN4 mutations as well as related animal studies [11]. 
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They further provide potential mechanisms underlying 
ACTN4-linked glomerulopathy.
The physiological function of ACTN4 is unlikely lim-
ited to bundling actin and co-activating transcription. 
It is likely to also be a signaling molecule that transmits 
extracellular signalings to influence cell growth and dif-
ferentiation. The intent of this thematic series is to 
summarize recent discoveries on actinin function and 
ACTN-related diseases and highlight future challenges in 
ACTN research.
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